FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1967492617> ?p ?o ?g. }

• W1967492617 endingPage "130" @default.
• W1967492617 startingPage "121" @default.
• W1967492617 abstract "Several naturally occurring cyclin-dependent kinase (CDK) inhibitors have been isolated from different lower organisms. In this report, we examined the effect of one of the CDK inhibitors, butyrolactone I (BL), on the expression of cyclins D2, A and B1 in three human prostatic cancer cell lines (DU145, PC-3, LNCaP) using two colored flow cytometric analysis. The percentage of DU145 cells in the 4C phase of the cell cycle were increased significantly at both 70 μM and 100 μM BL. Furthermore, an additional 8C peak was observed which had double the DNA content of the 4C phase at these concentrations of BL. The appearance of the 8C peak increased gradually and was more evident in DU145 and PC-3 than LNCaP. Cells in the 8C peak had either two nuclei or abnormal nuclei as observed by Papanicolaou stain. BL also increased the amount of cyclin B1 positive cells in the 4C phase. This increase was apparent on day 1 and returned to normal by day 3. Since BL selectively inhibits cyclin-dependent kinase, cyclin B1 might accumulate without being degraded. Other cyclins were not significantly changed by BL. The data demonstrate that BL inhibited Cdc2 of unsynchronized cultured prostate cancer cells, and interrupted the cell cycle progression toward cell division. The BL inhibition of Cdc2 led to the accumulation of cells in the 4C phase without mitosis resulting in an accumulation of cyclin B1. The appearance of cells in the 8C phase may be due to the progression of cells in the 4C phase through the cell cycle skipping mitosis. Cyclin B1 decreased in correlation with the progression through a new cell cycle. These results suggest that BL does not cause a complete arrest of the cell cycle in G2/M but that BL occasionally allows for the skipping of mitosis and subsequent progression through the cell cycle to occur." @default.
• W1967492617 created "2016-06-24" @default.
• W1967492617 creator A5033194585 @default.
• W1967492617 creator A5059333576 @default.
• W1967492617 creator A5059892943 @default.
• W1967492617 creator A5068217750 @default.
• W1967492617 creator A5076159797 @default.
• W1967492617 creator A5081577782 @default.
• W1967492617 date "1999-04-01" @default.
• W1967492617 modified "2023-10-17" @default.
• W1967492617 title "Butyrolactone I induces cyclin B1 and causes G2/M arrest and skipping of mitosis in human prostate cell lines" @default.
• W1967492617 cites W14542710 @default.
• W1967492617 cites W1631116077 @default.
• W1967492617 cites W1966406567 @default.
• W1967492617 cites W1974317236 @default.
• W1967492617 cites W1982254879 @default.
• W1967492617 cites W1985535995 @default.
• W1967492617 cites W1985795966 @default.
• W1967492617 cites W1998718563 @default.
• W1967492617 cites W2007993419 @default.
• W1967492617 cites W2008693579 @default.
• W1967492617 cites W2027376766 @default.
• W1967492617 cites W2029472887 @default.
• W1967492617 cites W2064294223 @default.
• W1967492617 cites W2085593164 @default.
• W1967492617 cites W2094957076 @default.
• W1967492617 cites W2114918609 @default.
• W1967492617 cites W2122013512 @default.
• W1967492617 cites W2135129680 @default.
• W1967492617 cites W2137330819 @default.
• W1967492617 cites W2138697269 @default.
• W1967492617 cites W2147215689 @default.
• W1967492617 doi "https://doi.org/10.1016/s0304-3835(98)00381-4" @default.
• W1967492617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10378783" @default.
• W1967492617 hasPublicationYear "1999" @default.
• W1967492617 type Work @default.
• W1967492617 sameAs 1967492617 @default.
• W1967492617 citedByCount "45" @default.
• W1967492617 countsByYear W19674926172012 @default.
• W1967492617 countsByYear W19674926172013 @default.
• W1967492617 countsByYear W19674926172014 @default.
• W1967492617 countsByYear W19674926172015 @default.
• W1967492617 countsByYear W19674926172016 @default.
• W1967492617 countsByYear W19674926172017 @default.
• W1967492617 countsByYear W19674926172018 @default.
• W1967492617 countsByYear W19674926172019 @default.
• W1967492617 countsByYear W19674926172020 @default.
• W1967492617 countsByYear W19674926172021 @default.
• W1967492617 countsByYear W19674926172022 @default.
• W1967492617 countsByYear W19674926172023 @default.
• W1967492617 crossrefType "journal-article" @default.
• W1967492617 hasAuthorship W1967492617A5033194585 @default.
• W1967492617 hasAuthorship W1967492617A5059333576 @default.
• W1967492617 hasAuthorship W1967492617A5059892943 @default.
• W1967492617 hasAuthorship W1967492617A5068217750 @default.
• W1967492617 hasAuthorship W1967492617A5076159797 @default.
• W1967492617 hasAuthorship W1967492617A5081577782 @default.
• W1967492617 hasConcept C120089663 @default.
• W1967492617 hasConcept C120504264 @default.
• W1967492617 hasConcept C121608353 @default.
• W1967492617 hasConcept C124320809 @default.
• W1967492617 hasConcept C1491633281 @default.
• W1967492617 hasConcept C153911025 @default.
• W1967492617 hasConcept C16438837 @default.
• W1967492617 hasConcept C2776438761 @default.
• W1967492617 hasConcept C2778437423 @default.
• W1967492617 hasConcept C2779723316 @default.
• W1967492617 hasConcept C29537977 @default.
• W1967492617 hasConcept C502942594 @default.
• W1967492617 hasConcept C54355233 @default.
• W1967492617 hasConcept C55493867 @default.
• W1967492617 hasConcept C86803240 @default.
• W1967492617 hasConcept C93304396 @default.
• W1967492617 hasConcept C95444343 @default.
• W1967492617 hasConcept C96232424 @default.
• W1967492617 hasConcept C9743823 @default.
• W1967492617 hasConceptScore W1967492617C120089663 @default.
• W1967492617 hasConceptScore W1967492617C120504264 @default.
• W1967492617 hasConceptScore W1967492617C121608353 @default.
• W1967492617 hasConceptScore W1967492617C124320809 @default.
• W1967492617 hasConceptScore W1967492617C1491633281 @default.
• W1967492617 hasConceptScore W1967492617C153911025 @default.
• W1967492617 hasConceptScore W1967492617C16438837 @default.
• W1967492617 hasConceptScore W1967492617C2776438761 @default.
• W1967492617 hasConceptScore W1967492617C2778437423 @default.
• W1967492617 hasConceptScore W1967492617C2779723316 @default.
• W1967492617 hasConceptScore W1967492617C29537977 @default.
• W1967492617 hasConceptScore W1967492617C502942594 @default.
• W1967492617 hasConceptScore W1967492617C54355233 @default.
• W1967492617 hasConceptScore W1967492617C55493867 @default.
• W1967492617 hasConceptScore W1967492617C86803240 @default.
• W1967492617 hasConceptScore W1967492617C93304396 @default.
• W1967492617 hasConceptScore W1967492617C95444343 @default.
• W1967492617 hasConceptScore W1967492617C96232424 @default.
• W1967492617 hasConceptScore W1967492617C9743823 @default.
• W1967492617 hasFunder F4320320912 @default.
• W1967492617 hasIssue "1-2" @default.
• W1967492617 hasLocation W19674926171 @default.

• next